Inspire Pharma gets $1.5M milestone payment

NEW YORK — Drug developer Inspire Pharmaceuticals Inc. said Friday it received a $1.3 million milestone payment for the dry eye treatment DE-089 from its Japanese partner Santen Pharmaceutical Co. Ltd. Inspire said it received the payment because Santen completed a late-stage trial of the drug,... [read full story]